We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Pharma Wins Right to Sell Generic Fentora in 2018
Barr Pharma Wins Right to Sell Generic Fentora in 2018
November 24, 2009
Cephalon has agreed to drop a patent suit against Barr Pharmaceuticals, allowing the company to market generic Fentora in the U.S. in 2018, a year before the disputed patents expire.